Lab-Grown Blood Offers Hope for Rare Types

Scientists are making strides in developing lab-grown red blood cells, offering a beacon of hope for individuals with extremely rare blood types. The current process for producing these cells in laboratories is prohibitively expensive and labor-intensive, with costs reaching over $70,000 for just a few teaspoons of blood, a process taking approximately three weeks.

A collaborative effort between The University of Queensland and Australian Red Cross Lifeblood, supported by a $2.5 million investment from SMART CRC, is focused on making this technology more accessible and efficient. Researchers aim to create a scaffolding system that allows cells to grow at high densities with reduced nutrient costs, moving from an 'old-fashioned Nokia phone' method to one more akin to a 'smartphone'.

This advancement is crucial for patients with unique transfusion needs, such as those with rare blood types like Para-Bombay, or for neonatal care. While lab-grown blood will not replace traditional donations, it promises to significantly improve healthcare for a small but critical segment of the population. Clinical trials are underway to assess the safety and effectiveness of these lab-grown cells compared to donated blood.